Pennant Investors »

Igm Biosciences shares owned by Pennant Investors

Quarter-by-quarter ownership of Igm Biosciences (IGMS) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Igm Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Igm Biosciences held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Igm Biosciences by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $626k 65k 9.65

More positions owned by Pennant Investors

Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Antero Res Call Option (AR)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Echostar Corp Cl A (SATS)
Alphabet Cap Stk Cl A (GOOGL)
Apple Put Option (AAPL)
Colfax Corp (ENOV)
ODP Corp. (ODP)
Perimeter Solutions Sa Common Stock (PRM)
Fibrogen (FGEN)
Arcutis Biotherapeutics (ARQT)
Altimmune Com New (ALT)
Fate Therapeutics (FATE)

View all positions for Pennant Investors

Top funds holding Igm Biosciences

Baker Bros. Advisors
T. Rowe Price Associates
Artal Group
Redmile Group
FMR
Goldman Sachs Group
RA Capital Management
Vanguard Group
BlackRock
Millennium Management
Geode Capital Management
Rhenman & Partners Asset Management AB
TD Asset Management
Samsara BioCapital
Northern Trust

View all funds holding Igm Biosciences